# Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex

> **NCT01486264** · PHASE4 · COMPLETED · sponsor: **Merz Pharmaceuticals GmbH** · enrollment: 283 (actual)

## Conditions studied

- Cervical Dystonia

## Interventions

- **BIOLOGICAL:** Xeomin®

## Key facts

- **NCT ID:** NCT01486264
- **Lead sponsor:** Merz Pharmaceuticals GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01-20
- **Primary completion:** 2016-03-29
- **Final completion:** 2016-03-29
- **Target enrollment:** 283 (ACTUAL)
- **Last updated:** 2022-10-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01486264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01486264, "Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01486264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*